Similar findings were reported by Famouri et al., who used a combination of Lactobacillus rhamnosus, Lactobacillus acidophilus, Bifidobacterium lactis, and Bifidobacterium bifidum for 12 weeks and concluded that obese children treated with this probiotic presented significantly lower levels of ALT, as well as an amelioration of liver steatosis if compared to the placebo group [99]. This evidence concerns the gene GPT and Hepatic steatosis.